Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vernooy, J. H. J.
Right arrow Articles by Wouters, E. F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vernooy, J. H. J.
Right arrow Articles by Wouters, E. F. M.
(Chest. 2004;126:1802-1810.)
© 2004 American College of Chest Physicians

Increased Activity of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Induced Sputum From Patients With COPD*

Juanita H. J. Vernooy, PhD; Jan H. N. Lindeman, MD, PhD; Jan A. Jacobs, MD, PhD; Roeland Hanemaaijer, PhD and Emiel F. M. Wouters, MD, PhD, FCCP

* From the Departments of Respiratory Medicine (Drs. Vernooy and Wouters) and Medical Microbiology (Dr. Jacobs), Nutrition and Toxicology Research Institute Maastricht, University Hospital Maastricht, Maastricht, the Netherlands; the Department of Vascular Surgery (Dr. Lindeman), Leiden University Medical Center, Leiden, the Netherlands; and the Department of Biomedical Research (Dr. Hanemaaijer), TNO Prevention and Health, Leiden, the Netherlands.

Correspondence to: Juanita H. J. Vernooy, PhD, Department of Respiratory Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands; e-mail: j.vernooy{at}pul.unimaas.nl

Background: The increased expression of matrix metalloproteinases (MMPs) is considered to be a key factor in the development of COPD. Net MMP activity represents a tightly regulated process, which is not addressed by conventional investigation methods such as messenger RNA or protein expression. Yet, quantitative data on MMP activity in the airways of COPD patients are lacking.

Methods: We used specific immunocapture assays to quantify the activity of MMP collagenase (ie, MMP-1, MMP-8, and MMP-13) and MMP gelatinase (ie, MMP-2 and MMP-9) in the induced sputum of COPD patients (17 patients; FEV1, 56% predicted) and healthy smokers (17 subjects; FEV1, 99% predicted).

Results: Levels of total and active MMP-8 and MMP-9 were significantly increased in COPD patients vs control subjects, whereas MMP-1 activity levels were similar in both groups. The activity of MMP-2 and MMP-13 remained below the detection threshold of the assays. MMP-8 and MMP-9 activity were strongly related to neutrophilia in both groups, and the results of immunohistochemistry tests on sputum cytospins showed that MMP-9 was expressed in both alveolar macrophages and neutrophils, whereas MMP-8 expression was exclusively observed in neutrophils. A positive correlation was found between sputum MMP-8 and MMP-9 activity and the degree of airflow limitation.

Conclusion: We demonstrate increased MMP-8 and MMP-9 activity in the airway compartment of patients with mild-to-moderate COPD. This study provides further evidence of an impaired proteinase-antiproteinase balance in COPD patients.

Key Words: airway inflammation • collagenase • COPD • gelatinase • immunocapture activity assay




This article has been cited by other articles:


Home page
ChestHome page
S. Baraldo, E. Bazzan, M. E. Zanin, G. Turato, S. Garbisa, P. Maestrelli, A. Papi, M. Miniati, L. M. Fabbri, R. Zuin, et al.
Matrix Metalloproteinase-2 Protein in Lung Periphery Is Related to COPD Progression
Chest, December 1, 2007; 132(6): 1733 - 1740.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. A.N. Verhoeven, F. L. Moll, J. A.F. Koekkoek, A. C. van der Wal, D. P.V. de Kleijn, J. P. P.M. de Vries, J. H. Verheijen, E. Velema, E. Busser, A. Schoneveld, et al.
Statin Treatment Is Not Associated With Consistent Alterations in Inflammatory Status of Carotid Atherosclerotic Plaques: A Retrospective Study in 378 Patients Undergoing Carotid Endarterectomy
Stroke, August 1, 2006; 37(8): 2054 - 2060.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K.-i. Inoue, H. Takano, T. Yoshikawa, and J.H.J. Vernooy
Protease-Antiprotease Imbalance in Inflammatory Diseases in the Lung
Chest, August 1, 2005; 128(2): 1069 - 1069.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.